Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed/refractory multiple myeloma (MM).
Publication
, Conference
Gasparetto, C; Lipe, B; Tuchman, S; Callander, NS; Lentzsch, S; Baljevic, M; Rossi, AC; Bahlis, NJ; White, D; Chen, C; Sutherland, HJ; Kotb, R ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gasparetto, C., Lipe, B., Tuchman, S., Callander, N. S., Lentzsch, S., Baljevic, M., … Schiller, G. J. (2020). Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed/refractory multiple myeloma (MM). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Gasparetto, Cristina, Brea Lipe, Sascha Tuchman, Natalie Scott Callander, Suzanne Lentzsch, Muhamed Baljevic, Adriana C. Rossi, et al. “Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed/refractory multiple myeloma (MM).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Gasparetto C, Lipe B, Tuchman S, Callander NS, Lentzsch S, Baljevic M, et al. Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed/refractory multiple myeloma (MM). In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Gasparetto, Cristina, et al. “Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed/refractory multiple myeloma (MM).” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Gasparetto C, Lipe B, Tuchman S, Callander NS, Lentzsch S, Baljevic M, Rossi AC, Bahlis NJ, White D, Chen C, Sutherland HJ, Kotb R, LeBlanc R, Sebag M, Venner CP, Bensinger W, Sheehan H, Ju Y, Kai K, Schiller GJ. Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed/refractory multiple myeloma (MM). JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences